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Treatment of AR42J cells wi~h dexamethasone leads to an enhanced formation of amylase-containing granules and facilitates their regulated 
secretion, Besides tile exocrine properties, AR4~ cells possess a specific uptake system for [~H]GABA. The stored GABA can be released upon 
pota.~sium depolarisation i a Ca-"-dependent manner. After treatment with dexamethasoae, potassium depolarisation fails to release GABA, but 
instead causes a Ca"*.dependent secretion of amylase. Since vesicles imilar to small synaptic vesicles of neurons have been identified in AR4~ 
cells, we suggest hat the regulated GABA release is mediated by this vesicle type. It is tentatively speculated that other epithelial ¢¢11s, which also 
contain small synaptic vesicles and amino acid neurotransmitters, ma~, release them in a similar fashion. 
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1. INTRODUCTION 
The pancreatic ell line, AR42J, derived from a rat 
pancreatic acinar carcinoma, is widely used for studies 
of exocrine secretion. The cells store amylase in gran- 
ules, which can be released after stimulation with bomb- 
esin, cholecystokinin (CCK), insulin and gastrin. How- 
ever, regulated secretion is only observed after a 
longterm treatment with dexamethasone [1-4]. 
AR42J cells express, in addition to the above men- 
tioned granules, a vesicle type, which resembles the 
small synaptic vesicles (SSV) of neurons, as revealed by 
immunoreplica nalysis and immunoelectron micros- 
copy [5]. In addition° AR42J cells contain considerable 
amounts of amino acid neurotransmitters (?'-aminobu- 
tyrlc acid (GABA), glycine and glutamate) [5]. These 
data suggest he existence of a vesicle type similar to 
SSV of neurons in AR42J cells. So far, studies concern- 
ing the function of  these vesicles are lacking. Here we 
demonstrate that AR42J cells secrete GABA and amy- 
lase by two separate pathways. 
2. MATERIALS AND METHODS 
2.1. Materials 
Bombesin, choleeystokinin octapeptide (CCK8), carbachol, dexa- 
methasone, nipeeotic acid, earbonyl cyanide 4-(trifluorom- 
ethoxy)phenylhydrazone (FCCP) and aminooxy acetic acid {AOAA) 
were purchased from Sigma, Manchen, Germany. [3H]GABA (specific 
activity 60 Ci/mmol) was from NEN, Dreeich, Germany. The Phade- 
bas amylase assay was obtained from Pharmacia, Freiburg. Germany. 
The BCA protein determination kit was from Pierce, Karlsruhe, Ger- 
Correspo,de,ce ,ddcess: G. Ahnerl-Hilger, Medizinische KHn:.k and 
Poliklinik, Abt. Gastroenterologie, Klinikum Steglitz, Frcie Univer- 
sitat Berlin, Hindenburgdamm 30, 1000 Berlin 45, Germany. 
many. DMEM, and trypsin/EDTA solution were from Gib¢o, and 
foetal calf serum from Biochrom, both Berlin, Germany. All other 
chemicals were of the purest grade commercially available. 
2.2. Methods 
AR4~ cells were obtained from the American Tissue Type Collec- 
tion and cultivated as given elsewhere [5]. Treatment with dexam- 
ethasone (10 -~ M fiaal concentration) was usually ~r fo rm~ 48 h 
after plating for 48 h. 
Cells were preincubated in Krebs-Ringer-HEPES (KR HEI)ES) 
buffer containing 130 mM NaCl, 4.7 mM KCi, 1.2 mM MeSOn, 2.5 
mM CaCI:, 11 mM glucose, 10 mM HEPES, pH 7.4. The buffer was 
e~changed for a fresh one containing 1 mM AOAA and 0.5/~Ci/ml 
[~H]GABA and the cells were incubated for 2 h at 37"C. Following 
three washes lbr 5 mix with fresh KR HEPES buffer, the e~lls wera 
removed from the culture dish by a short trypsin treatment and distrib- 
uted to incubation vials. After 20 mix at 30"C the medium was re- 
moved by a short centrifugation step, followed by aspiration. The cells 
were resuspended in fresh KR HEPES containing the various s~.~re- 
tagogues or in buffer where sodium was replaced by potassium. The 
stimulation was stopped after 20 rain at 30°C by centrifagation. Radi- 
oactivity was estimated in tile supernatant and in the cell pelle~ alter 
lysis with lysis buffer containing 130 mM Tris-HCI, 10 mM CaCI:, 75 
mM NaCI, pH 8, supplemented with 0.2% Triton X-100. [aH]GABA 
release was ~iven as a percentage of the radioactivity present at the 
beginning of the stimulation. The amount of amylase released and 
relain~l by the cells was determined in an aliquot of the superrmtant 
or tile cell lysate using the Phadeba~ assay. Amyla~ release was given 
as a percentage of total amylase present at the start of the e~l/gril~; t. 
Protein was determined using the BCA protein determination kit. 
Values usually represent the means of three samples +_ S.D. 
3. RESULTS 
AR42J cells took up [~H]GABA applied to the me- 
dium. Between 2-4 pmol GABA/mg protein was associ- 
ated with the cells. About 90% of the uptake was sodium 
dependent. Addition of l mM nipecotic acid or 20/~M 
FCCP caused a 407b or 95% inhibition of  the QABA 
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uptake, respectively. Pretreatment of cells with dexa- 
methasone (100 nM for 48 h) enhanced the sodium- 
dependent GABA uptake 1.5-fold, but the inhibition by 
nipecotic acid was reduced to about 20% or less in 
comparison to untreated cells. Elevating the K + concen- 
tration in the extracellular medium released [3H]GABA 
fi'om AR42J cells. A 1.5-2-fold stimulation over basal 
release was obse~'ved (Fig. 1, see also Tables I and II). 
Additio~a of CdCi.~ (50/,tM)0 which blocks voltage-de- 
pendent Ca 2. channels, did not affect basal GABA re- 
lease (10.5 +__ 0.4% in the absence and 8.5 _ 1.4% in the 
presence of CdC12) but abolished the GABA secretion 
stimulated by 50 mM potassium (15.7 -'2_ 2% in the ab- 
sence and 7 + 0.8% in the presence of CdCI2). 
Comparing untreated and dexamethasone-treated 
AR42J cells, it turned out that an elevated lr~ ÷ concen- 
tration only released GABA from control cells. No 
stimulated GABA secretion was observed after treat- 
merit with dexamethasone. Instead, dexamethasone- 
treated cells showed an increased amylase secretion, 
which was not observed in untreated cells (Table L Fig. 
1 and 2). The K+-stimulated release of either GABA 
from untreated or amylase from dexamethasone AR42J 
cells depended on the extracellular Ca2÷-concentration 
(Table II). 
Seeretagogues, like bombesine and CCK8, failed to 
stimulate GABA secretion from AR42J cells. As ex- 
pected these secretagogues stimulated amylase from 
dexamethasone-treated c lls (data not shown). Simi- 
larly, carbaehol released amylase only in dexam- 
ethasone-treated AR42J cells, but did not affect GABA 
secretion. Nicotine had no effect on the release of either 
secretory product (Fig. 3). The carbachol-induced amy- 
lase secretion was due to muscarinic receptor activation, 
for it could be blocked by atropine. Using dexam- 
ethasone-treated cells, 20/,tM carbachol stimulated am- 
ylase secretion from 1.5 + 0.3% to 3.3 + 0.3%. In the 
presence of atropine, amylase secretion was 1.5 +_. 0.2% 
and in combination with earbachol 1.4 _ 0.1%. 
Table i 
Comparison of  dexamcthasone-treated an untreated AR42J cells 
with respect o K~-stimulated secretion of  [~H]GABA or amylase 
K* (raM) [~H]GABA Amylase 
- dex dex 
25 110± 9.3 100-1-12 104± 3,7 182+32 
50 162____.21 88_____32 122_____ 11 238± 15 
100 156__ 8 88__+ 3 118_17  365+12 
AR42J cells, treated with de:~amethasone ( 100 nM) for 48 h, or control 
~l ls  were labeled with [~H]GABA and farther handled as given in 
Materials and Methods.  For  better comparison, values are expressed 
as a percentage of  the control. Release from cells treatc~l with 5.9 mM 
K" containing normal KR  HEPES was set at 100% and corresponded 
to the data given in Figs. 1-3. 
4. DISCUSSION 
Besides neurons, various neuroendocrine cells have 
been reported to express the GABA-synthesizing en- 
zyme, glutamate decarboxylase, and to contain GABA 
([6-12], for a review see [13]). Furthermore, many non- 
neuronal cells take up GABA by a sodium-dependent, 
carrier-mediated process, amongst hem glial [14], pan- 
creatic [15] and adrenal chromaftln cells [8,16]. In the 
central nervous system, GABA is stored in SSV and 
released by exocytosis from GABAergic neurons acting 
as an inhibitory transmitter via specific receptors (for a 
review see [17]). However, the functional properties of 
the GABA pools in non-neuronal cells arc poorly un- 
derstood. In bovine adrenal chromaffin cells, a stimu- 
lated GABA release was reported [8], which could not 
be reproduced by another group [16]. 
Evidence that non-neuronal cells possess a vesicle 
type comparable to the SVV of neurons, which could 
store amino acid neurotransmitters, came from very 
recent studies with AR42J cells. The amphicrine proper- 
ties of AR42J cells, characterized electronmicroscopi- 
tally by dense core granules and synaptophysin-con- 
tainin8 small vesicles with an electron translucent con- 
tent, suggest he presence of two secretory pathways in 
these cells [5]. In the same line, various neoplastic neu- 
roendocrine cells also contain large amounts of amino 
acid neurotransmitters and express integral membrane 
proteins of SSV, suggesting, again, the existence of a 
vesicle type analogous to neurons [18,19]. 
Here we show for the first time, in a permanent cell 
line~ that AR42J ceils contain not onl2¢ the ingredients 
for vesicular storage and release [5], but do release 
GABA by regulated secretion. A stimulated release was 
only observed by potassium depolarisation v,,hereas 
other seeretagogues failed to release GABA. More sur- 
Table I1 
Ca-'* dependency of  K"-stimulated release of [3H]GABA from un- 
treated" or of amylase fi'om denamethasone-treated t' AR42J cells 
K ÷ (haM) [-~H]GABA release Amylase release 
(% of  control) ~ (% of  control) b
with Ca:* without Ca2* with Ca ~+ without Ca'-* 
23 124 +_ 2,3 - - - 
40 140 _ 5.6 - - - 
75 166 + 7,8 80 __. 4.7 - - 
100 207+2.7  86+ 1,4 211 _+20 89~10 
"Preloaded AR42J cells were stimulated with KR HEPES containing 
the various K + concentrations given, either in the presence of 2.5 mM 
Ca .'+ or in its absence. Values are expressed as a percentage o1" the 
control (~ee Table 1). The basal release in the absence o f  Ca "~+ in- 
creased 2-fold for so far unknown reasons. 
h AR42J cell'~ were treated with dexamethasonc (100 nM) for 48 h and 
amylase release was stimulated either in the presence or absence of  
Ca ~*. Basal amylase secretion was not affected by the omission of  
Ca:'". 
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Fig. 1. K'-stimulatcd ['aHIGABA release by AR42J cells. Preloaded 
cells (see Materials and Methods) were stimulated with the K" concen- 
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Fig. 2. K*-stimulated release of amylase from dexamethasone-treated 
AR42J cells. AR42J cells were treated with dexamethasone (109 nM) 
for 48 b. Cells were labelled with [~H]GABA and stimulated with 
various K*-concentratlons given on the abscissa. [~H]GABA and am- 
ylase were estimated from the same sample. 
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Fig. 3. Effects of carbachol and nicotine on [~H]GABA and amylase 
~ecretion from untreated or dexamcthasone-treated AR42.I cells. 
AR4~ cells treated with dexamethasone (100 nM) control veils were 
labelled with ['~H]GA BA. The cells were stimulated for 20 rain at 30"C 
with the carbachol or nicotine concentrations given at the abscissa. 
Radioactivity and amylase in the supernatant and in the cell lysate 
were estimated from the same sample. 
plasma membrane component are affected by dexam- 
ethasone. 
In conclusion, AR42J cells represent a model system 
for the study of secretion for two reasons: (i) two sepa- 
rate regulated secretory processes can be studied simul- 
taneously within the same cell; (ii) the differential effects 
on secretion induced by dexamethasone may be used to 
learn more about the regulation of these two separately 
regulated secretory pathways. 
prisingly, only untreated cells showed a regulated 
GABA release, which disappeared after treatment with 
dexamethasone. Dexamethasone stops proliferation 
and leads to an exoerine phenotype, indicated by an 
increase of zymogen-like granules and amylase secre- 
tion ([1,2,21], and also this paper). However, neither the 
uptake of GABA nor the synaptophysin content (the 
most prominent marker of SSV) is affected after treat- 
ment with dexamethasone [5], and may therefore not 
explain our findings. Furthermore, the lack of a stimu- 
lated OABA secretion in dexamethasone-treated cellsis 
probably not due to a disappearance ofvoltage-depend- 
ent Ca v" channels [20], since a stimulated amylase secre- 
tion was still observed. Probably, other vesicle- or 
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